JP2017502039A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502039A5
JP2017502039A5 JP2016542216A JP2016542216A JP2017502039A5 JP 2017502039 A5 JP2017502039 A5 JP 2017502039A5 JP 2016542216 A JP2016542216 A JP 2016542216A JP 2016542216 A JP2016542216 A JP 2016542216A JP 2017502039 A5 JP2017502039 A5 JP 2017502039A5
Authority
JP
Japan
Prior art keywords
compound
formula
nitrogen
sulfur
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016542216A
Other languages
English (en)
Japanese (ja)
Other versions
JP6491214B2 (ja
JP2017502039A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072090 external-priority patent/WO2015138039A1/en
Publication of JP2017502039A publication Critical patent/JP2017502039A/ja
Publication of JP2017502039A5 publication Critical patent/JP2017502039A5/ja
Application granted granted Critical
Publication of JP6491214B2 publication Critical patent/JP6491214B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016542216A 2013-12-23 2014-12-23 放射性標識のための方法および試薬 Expired - Fee Related JP6491214B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361919901P 2013-12-23 2013-12-23
US61/919,901 2013-12-23
PCT/US2014/072090 WO2015138039A1 (en) 2013-12-23 2014-12-23 Methods and reagents for radiolabeling

Publications (3)

Publication Number Publication Date
JP2017502039A JP2017502039A (ja) 2017-01-19
JP2017502039A5 true JP2017502039A5 (enExample) 2018-02-01
JP6491214B2 JP6491214B2 (ja) 2019-03-27

Family

ID=54072256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016542216A Expired - Fee Related JP6491214B2 (ja) 2013-12-23 2014-12-23 放射性標識のための方法および試薬

Country Status (13)

Country Link
US (3) US9994573B2 (enExample)
EP (1) EP3086792B1 (enExample)
JP (1) JP6491214B2 (enExample)
KR (1) KR102325454B1 (enExample)
CN (1) CN106456645B (enExample)
AU (1) AU2014386214B2 (enExample)
BR (1) BR112016014758A8 (enExample)
CA (1) CA2934850C (enExample)
IL (1) IL246403B (enExample)
MX (1) MX2016008418A (enExample)
RU (1) RU2016128528A (enExample)
TW (1) TWI673279B (enExample)
WO (1) WO2015138039A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015138039A1 (en) 2013-12-23 2015-09-17 Memorial Sloan-Kettering Cancer Center Methods and reagents for radiolabeling
MX387627B (es) * 2014-09-17 2025-03-18 Memorial Sloan Kettering Cancer Center Formación de imágenes de inflamación e infección dirigida a hsp90 y terapia
WO2017002196A1 (ja) * 2015-06-30 2017-01-05 株式会社日立国際電気 整合器及び整合方法
KR102175125B1 (ko) * 2018-12-28 2020-11-05 울산과학기술원 미토콘드리아 표적 Hsp90 억제제 기반 화합물 및 이를 포함하는 광역학 치료를 위한 약학적 조성물
WO2022182731A1 (en) * 2021-02-24 2022-09-01 Samus Therapeutics, Inc. Sn-labeling and radiolabeling of epichaperome inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US20070178537A1 (en) * 2003-06-30 2007-08-02 Sloan-Kettering Institute For Cancer Research Assays for detection of bioactive compounds that interact with heat shock protein 90
US7834181B2 (en) 2005-02-01 2010-11-16 Slaon-Kettering Institute For Cancer Research Small-molecule Hsp90 inhibitors
US9403828B2 (en) 2005-02-01 2016-08-02 Sloan-Kettering Institute For Cancer Research Small-molecule Hsp90 inhibitors
WO2007134298A2 (en) 2006-05-12 2007-11-22 Myriad Genetics, Inc. Therapeutic compounds and their use in cancer
WO2008005937A2 (en) 2006-06-30 2008-01-10 Sloan-Kettering Institute For Cancer Research Treatment of neurodegenerative diseases through inhibiton of hsp90
KR101313804B1 (ko) 2007-03-20 2013-10-01 쿠리스 인코퍼레이션 Hsp90 억제제로서의 융합된 아미노 피리딘
NZ586129A (en) 2007-11-14 2012-06-29 Myrexis Inc Therapeutic compounds and their use in treating diseases and disorders
JP5941407B2 (ja) 2009-10-07 2016-06-29 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ Hsp90阻害剤
CN103596955B (zh) 2011-04-05 2016-11-16 索隆-基特林癌症研究协会 Hsp90抑制剂
JP6266506B2 (ja) 2011-04-05 2018-01-24 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ Hsp90阻害物質
BR112013027448A2 (pt) 2011-04-28 2020-09-01 Sloan-Kettering Institute For Cancer Research terapia de combinação com hsp90
EA201490230A1 (ru) 2011-07-08 2014-06-30 Слоан-Кеттеринг Инститьют Фор Кэнсер Рисерч Применение меченых ингибиторов hsp90
EP2972394A4 (en) * 2013-03-15 2016-11-02 Sloan Kettering Inst Cancer HSP90-DESIGNING AND THERAPY
SG11201601542SA (en) 2013-08-16 2016-04-28 Sloan Kettering Inst Cancer Selective grp94 inhibitors and uses thereof
WO2015138039A1 (en) 2013-12-23 2015-09-17 Memorial Sloan-Kettering Cancer Center Methods and reagents for radiolabeling
MX387627B (es) 2014-09-17 2025-03-18 Memorial Sloan Kettering Cancer Center Formación de imágenes de inflamación e infección dirigida a hsp90 y terapia
US20180280397A1 (en) 2015-10-05 2018-10-04 Memorial Sloan Kettering Cancer Center Rational combination therapy for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2017502039A5 (enExample)
CY1123670T1 (el) Κρυσταλλικο παραγωγο 6,7-ακορεστης-7-καρβαμοϋλ μορφινανης, και μεθοδος για την παραγωγη αυτου
AR076897A1 (es) Procesos para la produccion de acidos cicloalquilcarboxamido-piridina benzoicos
CY1116082T1 (el) Μεθοδος παρασκευης ενωσεων βενζαζεπινης ή αλατων τους
JP6782592B2 (ja) 含フッ素化合物の製造方法
MX2014005870A (es) Proceso para preparar compuestos de 1h -pirazol - 5 - carboxilato n - sustituidos y derivados de los mismos.
MX2017017022A (es) Metodo para la sintesis de derivados de rapamicina.
ES2408586T3 (es) Procedimiento para la producción de guanidinas bicíclicas mediante la utilización de una tiourea cíclica
RU2016128528A (ru) Способы и реактивы для введения радиоактивной метки
JP6519594B2 (ja) イソシアネート化合物の製造方法
JP2018501266A5 (enExample)
RU2009143867A (ru) Способы получения производных n-изобутил-n-(2-гидрокси-3-амино-4-фенилбутил)-пара-нитробензолсульфониламида
JP2010516644A5 (enExample)
MX379419B (es) Proceso para preparar compuestos de aminotioléster y sus sales.
WO2011132070A1 (en) Process for the preparation of 2-amino-substituted 1,3-benzothiazine-4-ones
CN104860856A (zh) 一种无碱绿色合成异硫氰酸酯的方法
Yekhlef et al. New method of synthesis of naphtylthioacetic acids 1-dialkylamides from 4-(1-naphthyl)-1, 2, 3-thiadiazole.
GB2557867A8 (en) New synthetic path to vortioxetine salts
JP2011506323A5 (enExample)
JP2017514845A5 (enExample)
JP2015044990A5 (enExample)
Ghorbani-Vaghei et al. A new and facile protocol for the synthesis of dithiocarbamate-linked 3, 4-dihydro-2H-pyran using N-halo catalysts under mild conditions reaction
JP6466107B2 (ja) 4−フェニルチオ−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法
Sahakyan et al. Synthesis of heterocyclic 1, 4-diamino-2, 3-dibromo-2-butenes.
AR052864A1 (es) Preparacion de cetoamidas